Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, MN, USA.
J Am Coll Surg. 2010 Feb;210(2):232-9. doi: 10.1016/j.jamcollsurg.2009.09.041. Epub 2009 Dec 3.
We evaluated the feasibility and oncologic durability of performing prostate biopsy and open radical retropubic prostatectomy (RRP) in patients who have previously undergone proctocolectomy and ileal pouch-anal anastomosis (PC-IPAA).
We performed a retrospective review of all patients at our institution who underwent an RRP after a PC-IPAA between June 1992 and February 2009. Variables evaluated included demographic characteristics, biopsy technique, tumor pathology, surgical technique, complications, and functional and oncologic outcomes.
Sixteen patients were identified. Mean prostate-specific antigen was 9.3 ng/mL (median, 5.9 ng/mL; range, 4.3 to 26.8 ng/mL). Prostatic biopsy was performed without complication by a variety of radiographic techniques. Successful RRP was achieved in all patients without pouch violation or pouch-related postoperative complications. The most common intraoperative finding was pelvic adhesions between the posterior prostate/seminal vesicles and the IPAA. Neurovascular bundle preservation was not altered by pelvic adhesions in any patient in whom this was the goal of the operation. Urinary continence was restored by 3 months in 94% of patients and erectile function returned without the use of medication in 73% who had neurovascular bundle preservation. Overall pouch function was subjectively unchanged postoperatively. Biochemical recurrence occurred in 3 patients and local recurrence in 2 patients. Only 1 recurrence occurred within 5 years of RRP during a mean follow-up of 5.7 years (median, 3.8 years; range, 0.3 to 14.5 years).
Despite altered pelvic anatomy from previous PC-IPAA, prostate biopsy and RRP can be done safely and effectively. Previous PC-IPAA should not be a contraindication to RRP in men with clinically localized prostate cancer.
我们评估了对先前接受过直肠结肠切除术和回肠储袋肛管吻合术(PC-IPAA)的患者进行前列腺活检和开放式经耻骨后前列腺切除术(RRP)的可行性和肿瘤学耐久性。
我们对 1992 年 6 月至 2009 年 2 月期间在我们机构接受 RRP 的所有患者进行了回顾性审查。评估的变量包括人口统计学特征、活检技术、肿瘤病理学、手术技术、并发症以及功能和肿瘤学结果。
确定了 16 名患者。平均前列腺特异性抗原为 9.3ng/mL(中位数为 5.9ng/mL;范围为 4.3 至 26.8ng/mL)。通过各种放射学技术进行前列腺活检均无并发症。所有患者均成功完成 RRP,无储袋侵犯或与储袋相关的术后并发症。最常见的术中发现是后前列腺/精囊与 IPAA 之间的盆腔粘连。在任何旨在保留神经血管束的患者中,盆腔粘连均未改变神经血管束的保留。94%的患者在 3 个月时恢复尿控,73%保留神经血管束的患者无需药物即可恢复勃起功能。总体而言,术后储袋功能主观上没有改变。3 名患者发生生化复发,2 名患者发生局部复发。仅在 RRP 后 5 年内发生 1 例复发,平均随访 5.7 年(中位数 3.8 年;范围 0.3 至 14.5 年)。
尽管先前的 PC-IPAA 改变了盆腔解剖结构,但前列腺活检和 RRP 可以安全有效地进行。对于患有临床局限性前列腺癌的男性,先前的 PC-IPAA 不应成为 RRP 的禁忌症。